Trial intelligence / Profile preview

Omega-3 fatty acid and epicardial fat thickness after acute myocardial infarction PCI

KCT0001591Phase 4Completed

Sponsor
Kuhnil Pharmaceutical
Start
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of omega-3 fatty acid in myocardial infarction (MI), sponsored by Kuhnil Pharmaceutical. Started Sep 2013; status: completed.

02

Drugs

omega-3 fatty acid
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on KCT0001591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call